Page 590 - Small Animal Clinical Nutrition 5th Edition
P. 590

612        Small Animal Clinical Nutrition



                                                                      (GALT) is likely to be very limited if the antigen is fed to a
                                                                      patient with a highly porous mucosal barrier. Irritable bowel
        VetBooks.ir  Box 31-1. Gastroscopic Food Sensitivity          syndrome is a disease of dogs characterized by chronic recurrent
                    Testing.
                                                                      abdominal  pain  and  large  bowel  diarrhea  (Guilford, 1996a).
                    Gastroscopic food sensitivity testing (GFST) is a diagnostic tech-  Feeding changes will often alleviate the signs of irritable bowel
                    nique in which food extracts (5,000 to 15,000 protein nitrogen  disease, implying that food sensitivity plays a role in this syn-
                    units/ml) are dripped onto the gastric mucosa by means of the  drome. In the experience of one of the authors (WGG), avoid-
                    operating channel of an endoscope. The site is then observed for  ing  gas-producing  foods  (e.g., homemade  vegetable-based
                    two to three minutes. Mucosal swelling suggests an immediate  foods) or foods with a high fat content is particularly advanta-
                    sensitivity to the food extract tested. Erythema, blanching, edema  geous  in  the  management  of  dogs  with  irritable  bowel  syn-
                    and petechiation at the mucosal site also suggest the test subject  drome. In affected dogs, the adverse reactions to these nutrients
                    is hypersensitive to the food, and the food, therefore, should not
                    be used as part of the sensitive patient’s diet. Sampling of the  are most likely due to food intolerance rather than food allergy.
                    mucosal  site  with  subsequent  measuring  of  histamine  levels,
                    other mediator levels or mast cell degranulation can be used to  Diagnostic Methods
                    determine  whether  the  response  was  immune  mediated. The  The diagnosis of an adverse reaction to a food is confirmed by
                    diagnostic accuracy of GFST isn’t known.          elimination-challenge trials (Jackson, 2009). In food-sensitive
                                                                      patients, resolution of clinical signs occurs after elimination of
                    The Bibliography for Box 31-1 can be found at     the responsible food from the diet followed by a return of the
                    www.markmorris.org.                               signs when the patient is challenged with the original food.
                                                                      Subsequently, feeding the elimination food should again allevi-
                                                                      ate clinical signs. Correct design of elimination-challenge trials
                                                                      is imperative for reliable diagnosis and is described below in the
                  their dermatoses (Scott et al, 2001; Paterson, 1995; Loeffler et  Feeding Plan section.
                  al, 2004, 2006).The increased frequency of defecation will nor-  Failure to challenge a suspected food-sensitive patient will
                  malize with use of an appropriate elimination food (Loeffler et  lead to marked over diagnosis of food sensitivity (Guilford et al,
                  al, 2004).                                          2001). However, whether to challenge the patient or not is a
                    There are at  least  five subacute  to  chronic  GI  conditions  decision that  needs  to  be  made  collectively with  the  owner.
                  thought  to  involve food  allergy in  people: 1)  food  protein-  Many owners are happy with a presumptive diagnosis of food
                  induced  enterocolitis, 2)  food-induced  colitis  syndrome, 3)  sensitivity and do not wish to undertake a challenge test. After
                  food-induced  malabsorption syndrome, 4)  gluten-sensitive  a diagnosis of food sensitivity is made, further cycles of elimi-
                  enteropathy and 5) allergic eosinophilic gastroenteritis (Samp-  nation-challenge trials may then be undertaken in an attempt
                  son, 1991; Sampson et al, 2001; Motala, 2008). All of these  to identify the responsible food ingredients. It is noteworthy
                  conditions can occur in dogs and cats. The role of food allergy  that dietary trials confirm or rule out adverse reactions to food
                  in canine and feline IBD is unknown. Hypersensitivity to food  but do not indicate the underlying mechanism (allergy or intol-
                  is probably involved in the pathogenesis of this syndrome; at  erance).
                  least some affected animals could be more appropriately diag-  The  place  of  skin  tests, laboratory  assays  and  endoscopic
                  nosed  as  suffering  from  food  protein-induced  enterocolitis.  provocation tests remains uncertain in the diagnosis of food
                  Dogs with GI diseases, including IBD, have more food aller-  sensitivity. None  of  these  are  suitable  as  screening  tests  for
                  gen-specific serum IgG than normal dogs, a finding that may  adverse reactions to food because they do not screen for the
                  reflect  increased  antigen  exposure  due  to  increased  mucosal  entire spectrum of adverse reactions to foods (both allergy and
                  permeability (Foster, 2003). Currently, 10% of dogs with IBD  intolerance). Some  tests  (e.g., measurement  of  food-specific
                  diagnosed by one of the authors (WGG) have positive gastro-  serum IgE) suggest that an adverse reaction to a particular food
                  scopic food sensitivity tests (GFST) to food antigens (Box 31-  (identified in an elimination-challenge trial) may be due to a
                  1). Positive GFST results to foods used in the treatment of the  type-1  hypersensitivity  response  rather  than  another  type  of
                  disease are often detected during followup endoscopic studies.  allergic reaction or a food intolerance. However, at the present
                  This finding strongly implies that food allergy is involved in the  time, intradermal  testing, radioallergosorbent  tests  (RASTs)
                  perpetuation of IBD but that it may not be the primary cause.  and enzyme-linked immunosorbent assays (ELISAs) for food
                  That is, inflammation of the mucosa predisposes animals to the  hypersensitivity are considered unreliable in patients with der-
                  development of acquired food allergies. Therefore, a change in  matologic (Jeffers et al, 1991; Kunkle and Horner, 1992) and
                  food antigens may temporarily reduce the immune-mediated  GI disease (Foster, 2003). Although it is sensible to avoid feed-
                  mucosal inflammatory response. The longevity of this amelio-  ing proteins that have caused positive gastroscopic or colono-
                  ration is questionable; however, because most of the so-called  scopic  food  sensitivity  tests  (especially  more  severe  reactions
                  “hypoallergenic” foods commonly used in veterinary medicine  such  as  edema  and  petechiation), the  diagnostic  accuracy  of
                  contain  intact  proteins  that  are  hypoallergenic  primarily  by  these endoscopic provocation tests requires further evaluation
                  virtue of their novelty to the host’s immune system. The dura-  (Guilford et al, 1994; Vaden et al, 2000; Allenspach et al, 2006)
                  tion of protein novelty to the gut-associated lymphoid tissue  as does the diagnostic accuracy of ultrasonography for food sen-
   585   586   587   588   589   590   591   592   593   594   595